Last Updated: November 9, 2026

Exela Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA

EXELA PHARMA has twenty-three approved drugs.

There are seventeen US patents protecting EXELA PHARMA drugs.

Summary for Exela Pharma

US Patents:	17
Tradenames:	20
Ingredients:	20
NDAs:	23

Drugs and US Patents for Exela Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Exela Pharma	NIPRIDE RTU IN SODIUM CHLORIDE 0.9%	sodium nitroprusside	SOLUTION;INTRAVENOUS	209387-002	Dec 7, 2017		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Exela Pharma	NIPRIDE RTU IN SODIUM CHLORIDE 0.9%	sodium nitroprusside	SOLUTION;INTRAVENOUS	209387-003	Jul 13, 2018	AP	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Exela Pharma	ELCYS	cysteine hydrochloride	SOLUTION;INTRAVENOUS	210660-001	Apr 16, 2019		RX	Yes	Yes	11,648,262	⤷ Start Trial	Y			⤷ Start Trial
Exela Pharma	ELCYS	cysteine hydrochloride	SOLUTION;INTRAVENOUS	210660-001	Apr 16, 2019		RX	Yes	Yes	11,969,439	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.